logo

For the Inventor, By the Inventor

Hørsholm, Denmark

Ulla S Weis-Fogh

This inventor holds 4 USPTO granted patents. Top assignees: Bristol-Myers Squibb Compnay, Other. Active years: 1994-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ulla S Weis-Fogh. Retrieved from https://idiyas.com/inventor/ulla-s-weis-fogh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4

% Patents Active = 100.0

Average Co-Inventor Count = 1.7

ph-index = 4

Forward Citations = 327(Granted Patents)


Location History:

  • DK-2970 Horsholm, DK (1994 - 1996)
  • Hoersholm, DK (1998)

Company Filing History:

goldMedal2 out of 3,745 
 
Bristol-Myers Squibb Compnay
 patents
silverMedal2 out of 834,601 
Other
 patents

Years Active: 1994-1998

Loading Chart...
4 patents (USPTO):Explore Patents
1. 5795780 - Method of use of autologous thrombin blood fraction in a cell culture (1998-08-18),
2. 5795571 - Composition containing autologous thrombin blood fraction for use in a (1998-08-18),
3. 5480378 - Apparatus for preparing a concentrate of coagulation factors from a (1996-01-02),
4. 5318782 - Method for preparing tissue repair promoting substances (1994-06-07),

Title: Ulla S Weis-Fogh: Innovator in Medical Applications of Thrombin

Introduction

Ulla S Weis-Fogh is a prominent inventor based in Horsholm, Denmark. She has made significant contributions to the field of medical procedures, particularly through her innovative use of thrombin. With a total of 4 patents, her work has garnered attention for its potential applications in animal medicine.

Latest Patents

Among her latest patents, Ulla has developed a composition containing autologous thrombin blood fraction for use in medical procedures. This invention focuses on the application of thrombin, specifically a thrombin blood fraction that is autologous to the animal undergoing the procedure. Another notable patent involves a method of using autologous thrombin blood fraction in cell culture, further emphasizing her commitment to advancing medical practices.

Career Highlights

Throughout her career, Ulla has worked with notable companies, including Bristol-Myers Squibb Company. Her experience in such esteemed organizations has allowed her to refine her expertise and contribute to groundbreaking innovations in her field.

Collaborations

Ulla has collaborated with esteemed colleagues, including Stewart A Cederholm-Williams and Niels Erik Holm. These partnerships have played a crucial role in her research and development efforts.

Conclusion

Ulla S Weis-Fogh's contributions to the medical field through her innovative use of thrombin highlight her status as a leading inventor. Her work continues to pave the way for advancements in medical procedures, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…